首页 | 本学科首页   官方微博 | 高级检索  
     

两份脐血联合移植治疗成人慢性粒细胞性白血病一例
引用本文:何静松,黄河,蔡真,李黎,叶琇锦,张洁,胡晓蓉,金爱云,林茂芳. 两份脐血联合移植治疗成人慢性粒细胞性白血病一例[J]. 中国实验血液学杂志, 2003, 11(5): 508-511
作者姓名:何静松  黄河  蔡真  李黎  叶琇锦  张洁  胡晓蓉  金爱云  林茂芳
作者单位:浙江大学医学院附属第一医院骨髓移植中心,杭州,310003
摘    要:为了探讨两份非亲缘供者脐血联合移植治疗成人血液系恶性肿瘤患者的造血重建及移植相关性并发症 ,对 1例成人慢性粒细胞性白血病患者进行两份非亲缘供者脐血联合移植。预处理采用白消安 /环磷酰胺 (Bu/Cy)方案。移植物抗宿主病 (GVHD)的预防采用霉酚酸酯 (MMF)联合环孢霉素 (CsA)和短程氨甲喋呤 (MTX )方案。移植总单个核细胞数为 4.63× 10 7/kg ,CD3 4 + 细胞数为 8.3 4× 10 5 /kg。采用PCR法测定患者外周血细胞短串重复序列 (STR)获取植入证据。结果表明 :患者于移植后 2 3天外周血中性粒细胞绝对值 >0 .5× 10 9/L ,移植后 3 3天外周血血小板 >2 0× 10 9/L ,移植后 47天血小板 >50× 10 9/L。移植后 ,患者Ph染色体转阴性 ,bcr/abl融合基因阴性。移植后 3 1天 ,46天及 71天查外周血STR显示其中 1份脐血完全植入。患者于移植后 13天出现Ⅱ度急性GVHD ,经治疗后消失。结论 :脐血联合移植可用于成人恶性血液病的治疗 ,多份脐血联合移植可能是解决单个核细胞数偏低问题的途径之一

关 键 词:脐血移植 异基因遣血干细胞移植 慢性粒细胞性白血病
文章编号:1009-2137(2003)05-0508-04
修稿时间:2002-11-18

Treatment of One Case of Adult Chronic Myelogenous Leukemia by Two Units of Unrelated Umbilical Cord Blood Transplantation
HE Jing-Song,HUANG He,CAI Zhen,LI Li,YE Xiu-Jin,ZHANG Jie,HU Xiao -Rong,JIN Ai-Yun,LIN Mao-Fang Center of Bone Marrow Transplantation,The First Affiliated Hospital,M edical College,Zhejiang University,Hangzhou ,China. Treatment of One Case of Adult Chronic Myelogenous Leukemia by Two Units of Unrelated Umbilical Cord Blood Transplantation[J]. Journal of experimental hematology, 2003, 11(5): 508-511
Authors:HE Jing-Song  HUANG He  CAI Zhen  LI Li  YE Xiu-Jin  ZHANG Jie  HU Xiao -Rong  JIN Ai-Yun  LIN Mao-Fang Center of Bone Marrow Transplantation  The First Affiliated Hospital  M edical College  Zhejiang University  Hangzhou   China
Affiliation:Center of Bone Marrow Transplantation, The First Affiliated Hospital, Medical College, Zhejiang University, Hangzhou 310003, China.
Abstract:To explore the hematopoietic reconstitution and transplantation-related complications of two units of unrelated umbilical cord blood combined transplantation for the treatment of adult hematologic malignancies, one adult patient with chronic myelogenous leukemia received two units of unrelated umbilical cord blood combined transplantation. The conditioning regimen was busulfan and cyclophosphamide (Bu-Cy). GVHD prophylaxis regimen consisted of mycophenolate mofetil (MMF), cyclosporine A (CsA) and methotrexate (MTX). The patient received total nucleated cells 4.63 x 10(7)/kg with CD34+ cells 8.34 x 10(5)/kg. Engraftment was documented by the analysis of short tandem repeat with polymerase chain reaction (STR-PCR). The results showed that the STR-PCR analysis for peripheral blood at day 31, 46 and 71 after transplantation suggested that one of two units of cord blood were completely engrafted. The ANC > 0.5 x 10(9)/L in the patient occurred at day 23, blood platelet counts > 20 x 10(9)/L at day 33 and > 50 x 10(9)/L at day 47. The Philadelphia chromosome and bcr/abl fusion gene of the patient also turned to negative after engraftment. Acute GVHD grade II occurred at day 13 and cured after treatment. It is concluded that umbilical cord blood can be used in adult hematopoietic stem cell transplantation. Two or more units umbilical cord blood combined transplantation might be the way to solve the problem of the low counts of nucleated cells when be used for adult.
Keywords:umbilical cord blood transplantation  allogenic hem atopoietic stem cell transplantation  chronic myelogenous leukemia
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号